Results 61 to 70 of about 4,961,010 (265)

A case report of subclinical primary aldosterone complicating with subclinical Cushing syndrome and literature review [PDF]

Zhenduanxue lilun yu shijian, 2023
This case reports a rare subclinical primary aldosteronism complicated with subclinical Cushing’s syndrome. A 41-year-old female patient was admitted for adrenal incidentaloma, had no clinical manifestations of typical primary aldosteronism or Cushing ...
HOU Yiru, WANG Min, WANG Chunhua, CHEN Yujie
doaj   +1 more source

11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial

Journal of Hypertension, 2022
Objective: Adrenal vein sampling (AVS) is recommended to subtype primary aldosteronism, but it is technically challenging. We compared 11C-Metomidate-PET-computed tomography (PET-CT) and AVS for subtyping of primary aldosteronism.
T. Puar, C. Khoo, C. Tan, A. Tong, Michael Chien Sheng Tan, A. E. Teo, K. Ng, Kang Min Wong, A. Reilhac, J. O’Doherty, C. Gomez-Sanchez, P. Kek, S. Yee, A. Tan, Matthew Chuah, Daphne Hui Min Lee, K. W. Wang, C. Zheng, Luming Shi, E. Robins, Roger S Foo   +20 more
semanticscholar   +1 more source

Primary aldosteronism concurrent with subclinical Cushing’s syndrome: a case report and review of the literature

Journal of Medical Case Reports, 2020
Background The prevalence of primary aldosteronism concurrent with subclinical Cushing’s syndrome was higher than previously thought. Through analyzing a rare clinical case, we summarized the diagnosis and management of primary aldosteronism with ...
Yingxiao Zhang, Jianyu Tan, Qin Yang, Zhipeng Du, Shumin Yang, Wenwen He, Ying Song, Jinbo Hu, Yi Yang, Qifu Li, Yao Zhang, Yunfeng He, Qingfeng Cheng, the Chongqing Primary Aldosteronism Study (CONPASS) Group   +13 more
doaj   +1 more source

The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy

Journal of Clinical Endocrinology and Metabolism, 2021
Context Diagnosis of primary aldosteronism (PA) for many patients depends on positive results for the saline infusion test (SIT). Plasma aldosterone is often measured by immunoassays, which can return inaccurate results.
G. Eisenhofer, Max Kurlbaum, M. Peitzsch, G. Constantinescu, H. Remde, M. Schulze, Denise Kaden, L. Müller, C. Fuss, S. Kunz, S. Kolodziejczyk-kruk, Sven Gruber, A. Prejbisz, F. Beuschlein, T. Williams, M. Reincke, J. Lenders, M. Bidlingmaier   +17 more
semanticscholar   +1 more source

A Rare Aldosterone-Producing Adenoma Detected by 68Ga-pentixafor PET-CT: A Case Report and Literature Review

Frontiers in Endocrinology, 2019
Context: Primary aldosteronism represents an important and common cause of hypertension and is characterized by autonomous aldosterone secretion that results in severe hypertension and hypokalemia.
Yunying Cui, Yushi Zhang, Jie Ding, Huiping Wang, Xiaoshen Ma, Ou Wang, Xiaoyan Chang, Hao Sun, Li Huo, Anli Tong   +9 more
doaj   +1 more source

Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background While both renin‐dependent and renin‐independent aldosterone secretion contribute to aldosteronism, their relative associations with cardiovascular disease (CVD) risk has not been investigated.
Jinbo Hu, Hang Shen, Peiqi Huo, Jun Yang, Peter J Fuller, Kanran Wang, Yi Yang, Linqiang Ma, Qingfeng Cheng, Lilin Gong, Wenwen He, Ting Luo, Mei Mei, Yue Wang, Zhipeng Du, Rong Luo, Jun Cai, Qifu Li, Ying Song, Shumin Yang   +19 more
doaj   +1 more source

Primary Aldosteronism, Aldosterone, and Extracellular Vesicles

Endocrinology, 2021
Abstract Primary aldosteronism (PA) is an endocrine related condition leading to arterial hypertension due to inappropriately high and unregulated aldosterone concentration. Recently, a broad spectrum of PA has been recognized, which brings new challenges associated with early identification of this condition that affect renal epithelial
Cristian A Carvajal, Alejandra Tapia-Castillo, Jorge A Pérez, Carlos E Fardella   +3 more
openaire   +2 more sources

Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism

Endocrine Journal
Pheochromocytoma is a rare form of adrenal hypertension. This study aimed to investigate the clinical characteristics and associated genetic mutations in patients with pheochromocytoma and primary aldosteronism.
Xurong Mai, Mitsuhiro Kometani, Toshiaki Kato, Ko Aiga, Shigehiro Karashima, Daisuke Aono, Seigo Konishi, Koshiro Nishimoto, Kazuyoshi Hosomichi, Atsushi Watanabe, Yuko Noda, Yoshiyu Takeda, Takashi Yoneda   +12 more
doaj   +1 more source

Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.

Journal of Hypertension, 2020
: Autonomous aldosterone overproduction represents the underlying condition of 5-10% of patients with arterial hypertension and carries a significant burden of mortality and morbidity.
P. Mulatero, S. Monticone, J. Deinum, L. Amar, A. Prejbisz, M. Zennaro, F. Beuschlein, G. Rossi, T. Nishikawa, A. Morganti, T. Seccia, Yen-Hung Lin, F. Fallo, J. Widimský   +13 more
semanticscholar   +1 more source

Mapping CSC‐Mediated Ovarian Cancer Chemoresistance via CXCR4‐PET to Guide Precision Cisplatin Re‐Sensitization Therapy

Advanced Science, EarlyView.
CXCR4 functions as a potential cancer stem cell‐associated marker linked to chemoresistance in ovarian cancer, and an inhibitor of CXCR4, AMD3100, can enhance the cytotoxic response to cisplatin. Based on these findings, [68Ga]Ga‐Pentixafor positron emission tomography enables selective visualization of CXCR4‐high ovarian cancer, while AMD3100 combined
Lixia Feng, Simei Zhao, Zheng Wei, Wenwen Wang, Feiquan Ying, Lin Huang, Mengna Zhu, Mengqing Chen, Qiang Yang, Si Sun, Dawei Jiang, Lingling Gao, Jing Cai   +12 more
wiley   +1 more source